CD109 REGULATES TUMOR PROPAGATION OF RADIORESISTANT GLIOMA STEM CELLS

被引:0
|
作者
Audia, Alessandra [1 ]
Minata, Mutsuko [2 ]
Guo, Xing [3 ]
Mukheef, Farah [1 ]
Patel, Hetshree [1 ]
Ezhilarasan, Ravesanker [4 ]
Sulman, Erik [5 ]
Nakano, Ichiro [6 ]
Bhat, Krishna [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[2] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA
[3] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol & Translat Mol Pathol, Houston, TX 77030 USA
[6] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
STMC-36
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [41] Tumor vasculature and glioma stem cells: Contributions to glioma progression
    Jhaveri, Niyati
    Chen, Thomas C.
    Hofman, Florence M.
    CANCER LETTERS, 2016, 380 (02) : 545 - 551
  • [42] CD109 Restrains Activation of Cutaneous IL-17-Producing γδ T Cells by Commensal Microbiota
    Zhang, Hualin
    Carnevale, Giustino
    Polese, Barbara
    Simard, Melissa
    Thurairajah, Bavanitha
    Khan, Nargis
    Gentile, Maria E.
    Fontes, Ghislaine
    Vinh, Donald C.
    Pouliot, Roxane
    King, Irah L.
    CELL REPORTS, 2019, 29 (02): : 391 - +
  • [43] Comparison of the expressions of CD109 and CD135 on CD34+ cells in human marrow, cord blood, and peripheral blood.
    Yu, JF
    Law, CS
    Law, P
    Yang, XF
    McDaniel, P
    Ball, ED
    Chen, Z
    BLOOD, 1999, 94 (10) : 136B - 136B
  • [44] CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation
    Boles, Nathan C.
    Lin, Kuanyin K.
    Lukov, Georgi L.
    Bowman, Teresa V.
    Baldridge, Megan T.
    Goodell, Margaret A.
    BLOOD, 2011, 118 (01) : 80 - 87
  • [45] CHLOROQUINE SUPPRESSES GLIOMA CELL VIABILITY AND SENSITIZES RADIORESISTANT STEM-LIKE GLIOMA CELLS TO IONIZING RADIATION AND CHEMOTHERAPY
    Kim, Ella L.
    Schulz-Schaeffer, Walter
    Deppert, Wolfgang
    Pilzak, Agatha A.
    Richter, Christoph
    Schmitz-Salue, Christoph
    Rave-Fraenk, Margret
    Rohde, Veit
    Giese, Alf
    NEURO-ONCOLOGY, 2009, 11 (06) : 917 - 917
  • [46] High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
    Emori, Makoto
    Tsukahara, Tomohide
    Murase, Masaki
    Kano, Masanobu
    Murata, Kenji
    Takahashi, Akari
    Kubo, Terufumi
    Asanuma, Hiroko
    Yasuda, Kazuyo
    Kochin, Vitaly
    Kaya, Mitsunori
    Nagoya, Satoshi
    Nishio, Jun
    Iwasaki, Hiroshi
    Sonoda, Tomoko
    Hasegawa, Tadashi
    Torigoe, Toshihiko
    Wada, Takuro
    Yamashita, Toshihiko
    Sato, Noriyuki
    PLOS ONE, 2013, 8 (12):
  • [47] Use of DNA-generated gold nanoparticles to radiosensitize and eradicate radioresistant glioma stem cells
    Kunoh, Tatsuki
    Shimura, Tsutomu
    Kasai, Tomonari
    Matsumoto, Syuji
    Mahmud, Hafizah
    Khayrani, Apriliana Cahya
    Seno, Masaharu
    Kunoh, Hitoshi
    Takada, Jun
    NANOTECHNOLOGY, 2019, 30 (05)
  • [48] Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment
    Chan, Ryan
    Sethi, Pallavi
    Jyoti, Amar
    McGarry, Ronald
    Upreti, Meenakshi
    RADIATION RESEARCH, 2016, 185 (02) : 169 - 181
  • [49] Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression
    Fan, Junyu
    Wang, Qian
    Zhang, Zhuoya
    Sun, Lingyun
    DRUG DEVELOPMENT RESEARCH, 2019, 80 (07) : 992 - 999
  • [50] OLIGODENDROCYTE PROGENITOR CELLS AND MACROPHAGES/ MICROGLIA INDUCE CHEMO-RADIORESISTANT ABILITIES IN GLIOMA CELLS AT THE TUMOR BORDER
    Hide, Takuichiro
    Komohara, Yoshihiro
    Nakamura, Hideo
    Makino, Keishi
    Yano, Shigetoshi
    Shibahara, Ichiyo
    Kumabe, Toshihiro
    Mukasa, Akitake
    NEURO-ONCOLOGY, 2018, 20 : 266 - 266